Equities

Pacs Group Inc

PACS:NYQ

Pacs Group Inc

Actions
Health CareHealth Care Providers
  • Price (USD)21.33
  • Today's Change1.50 / 7.56%
  • Shares traded3.94m
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Nov 09 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 19-Sep-24
  • 17-Oct-24
  • 07-Nov-24
Select bar for recommendation details.
Recommendations07-Nov-24
Buy2
Outperform5
Hold0
Sell0
Strong Sell0

Share price forecast in USD

The 7 analysts offering 12 month price targets for PACS Group Inc have a median target of 42.00, with a high estimate of 50.00 and a low estimate of 32.00. The median estimate represents a 96.91% increase from the last price of 21.33.
High134.4%50.00
Med96.9%42.00
Low50.0%32.00

Dividends

Historical dividend information is not available for Pacs Group Inc.
Div growth (TTM)--
More ▼

Earnings history & estimates in USD

On Aug 12, 2024, PACS Group Inc reported 2nd quarter 2024 losses of -0.07 per share.
More ▼

Revenue history & estimates in USD

PACS Group Inc had 2nd quarter 2024 revenues of 981.85m. This bettered the 916.50m consensus of the 7 analysts covering the company. The same period last year the company did not report revenues.
Average growth rate+5.04%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.